Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2018

Open Access 01-12-2018 | Case report

Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report

Authors: Sohgo Tsutsumi, Takashi Kawahara, Yusuke Hattori, Taku Mochizuki, Jun-ichi Teranishi, Kazuhide Makiyama, Yasuhide Miyoshi, Masako Otani, Hiroji Uemura

Published in: Journal of Medical Case Reports | Issue 1/2018

Login to get access

Abstract

Background

Female urethral carcinoma is a very rare disease that accounts for 0.02% of malignant diseases in female patients.

Case presentation

A 70-year-old Asian Japanese woman with a urethral tumor was referred to our hospital to undergo further examination. Biopsy specimens showed urethral adenocarcinoma that was positive for prostate-specific antigen. Her serum prostate-specific antigen level before surgery was 34.4 ng/ml. Urethral tumor resection with pelvic lymph node resection was performed. Her serum prostate-specific antigen level decreased to < 0.01 ng/ml after surgery.

Conclusions

We report a very rare case of Skene duct adenocarcinoma in a female patient with serum prostate-specific antigen elevation.
Literature
1.
go back to reference Derksen JW, Visser O, de la Riviere GB, Meuleman EJ, Heldeweg EA, Lagerveld BW. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol. 2013;31:147–53.CrossRefPubMed Derksen JW, Visser O, de la Riviere GB, Meuleman EJ, Heldeweg EA, Lagerveld BW. Primary urethral carcinoma in females: an epidemiologic study on demographical factors, histological types, tumour stage and survival. World J Urol. 2013;31:147–53.CrossRefPubMed
2.
go back to reference Zaviacic M, Ablin RJ. The female prostate and prostate-specific antigen: immunohistochemical localization, implications of this prostate marker in women and reasons for using the term “prostate” in the human female. Histol Histopathol. 2000;15:131–42.PubMed Zaviacic M, Ablin RJ. The female prostate and prostate-specific antigen: immunohistochemical localization, implications of this prostate marker in women and reasons for using the term “prostate” in the human female. Histol Histopathol. 2000;15:131–42.PubMed
3.
go back to reference Imamura Y, Sadar MD. Androgen receptor targeted therapies in castration-resistant prostate cancer: bench to clinic. Int J Urol. 2016;23:654–65.CrossRefPubMed Imamura Y, Sadar MD. Androgen receptor targeted therapies in castration-resistant prostate cancer: bench to clinic. Int J Urol. 2016;23:654–65.CrossRefPubMed
4.
go back to reference Kageyama S, Isono T, Iwaki H, et al. Proteome research in urothelial carcinoma. Int J Urol. 2015;22:621–8.CrossRefPubMed Kageyama S, Isono T, Iwaki H, et al. Proteome research in urothelial carcinoma. Int J Urol. 2015;22:621–8.CrossRefPubMed
5.
go back to reference Miyai M, Ebisuno S. A case of clear cell adenocarcinoma of the female urethra [in Japanese]. Hinyokika Kiyo. 1995;41:479–83.PubMed Miyai M, Ebisuno S. A case of clear cell adenocarcinoma of the female urethra [in Japanese]. Hinyokika Kiyo. 1995;41:479–83.PubMed
6.
go back to reference Gheiler EL, Tefilli MV, Tiguert R, de Oliveira JG, Pontes JE, Wood Jr DP. Management of primary urethral cancer. Urology. 1998;52:487–93.CrossRefPubMed Gheiler EL, Tefilli MV, Tiguert R, de Oliveira JG, Pontes JE, Wood Jr DP. Management of primary urethral cancer. Urology. 1998;52:487–93.CrossRefPubMed
7.
go back to reference Yamada Y, Takahashi A, Kanemura M, Minowada S, Homma Y. Primary carcinoma of the female urethra: report of 4 cases [in Japanese]. Nihon Hinyokika Gakkai Zasshi. 2012;103:675–80.PubMed Yamada Y, Takahashi A, Kanemura M, Minowada S, Homma Y. Primary carcinoma of the female urethra: report of 4 cases [in Japanese]. Nihon Hinyokika Gakkai Zasshi. 2012;103:675–80.PubMed
8.
9.
go back to reference Karnes RJ, Breau RH, Lightner DJ. Surgery for urethral cancer. Urol Clin North Am. 2010;37:445–57.CrossRefPubMed Karnes RJ, Breau RH, Lightner DJ. Surgery for urethral cancer. Urol Clin North Am. 2010;37:445–57.CrossRefPubMed
10.
go back to reference Dayyani F, Pettaway CA, Kamat AM, Munsell MF, Sircar K, Pagliaro LC. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol. 2013;31:1171–7.CrossRefPubMed Dayyani F, Pettaway CA, Kamat AM, Munsell MF, Sircar K, Pagliaro LC. Retrospective analysis of survival outcomes and the role of cisplatin-based chemotherapy in patients with urethral carcinomas referred to medical oncologists. Urol Oncol. 2013;31:1171–7.CrossRefPubMed
11.
go back to reference Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra: results of radiation therapy. Cancer. 1993;71:3102–8.CrossRefPubMed Garden AS, Zagars GK, Delclos L. Primary carcinoma of the female urethra: results of radiation therapy. Cancer. 1993;71:3102–8.CrossRefPubMed
12.
go back to reference Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol. 1998;82:835–41.CrossRefPubMed Dalbagni G, Zhang ZF, Lacombe L, Herr HW. Female urethral carcinoma: an analysis of treatment outcome and a plea for a standardized management strategy. Br J Urol. 1998;82:835–41.CrossRefPubMed
Metadata
Title
Skene duct adenocarcinoma in a patient with an elevated serum prostate-specific antigen level: a case report
Authors
Sohgo Tsutsumi
Takashi Kawahara
Yusuke Hattori
Taku Mochizuki
Jun-ichi Teranishi
Kazuhide Makiyama
Yasuhide Miyoshi
Masako Otani
Hiroji Uemura
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2018
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1558-y

Other articles of this Issue 1/2018

Journal of Medical Case Reports 1/2018 Go to the issue